InvestorsHub Logo
Replies to #244 on Biotech Values

drbio45

11/03/03 1:20 PM

#245 RE: DewDiligence #244

Oxigene's drug has a different method of action from squalamine, if it does work they probably would complement each other.

I would think Qlti is probably afraid of non-invasive competitors like squalamine and oxigene's drug.